Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin in Adolescent and Pediatric Lupus Nephritis (VOCAL)
NCT05288855Phase 3Terminated
- Sponsor
- Aurinia
- Start
- Oct 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of voclosporin in lupus nephritis (LN), sponsored by Aurinia. Primary endpoint: Proportion of subjects with renal response at 24 weeks. Started Oct 2023; status: terminated.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT05288855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05288855.